Catalyst Wire Dossier

Diseases Search Methodology Pricing Log in Sign up free

Diseases · Transitional Cell Carcinoma of the Bladder

Transitional Cell Carcinoma of the Bladder

📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Bladder.

Top drugs studied for this disease

Gemcitabine (6)
Mitomycin-C (3)
PACLITAXEL (2)
CARBOPLATIN (2)
CISPLATIN (2)
rogaflatinib (BAY1163877) (1)
Recombinant adenovirus (1)
PF-03446962 (1)
tesetaxel (1)
Mycobacterium w (1)

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

No documents found for this filter.

Catalyst Wire Dossier

FDA, ClinicalTrials.gov, and EMA — organized by disease, AI-summarized. Daily updates.

Catalyst Wire family

Dossier SEC FDA Frontier Briefing

Stay updated

Website

Daily FDA actions. One-time €1 verification charge; no recurring payment. Confirm by email, unsubscribe anytime.

Data: openFDA, ClinicalTrials.gov, EMA. Analysis by GPT-5-nano. Not medical advice. · Methodology · Privacy · Terms